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Supplementary Figure 1.  Simulated-annealing omit electron density for Crystal I.  (a) Portion 
of the composite simulated annealing-omit 2|Fo|-|Fc| electron density map calculated with the 
refined Crystal I model and all reflections extending to 2.2 Å resolution, contoured at 1.0 and 3.0 
σ (blue and red mesh, respectively).  (b) Portion of an omit-anneal 2|Fo|-|Fc| electron density map 
calculated with the refined Crystal I model and all reflections extending to 2.2 Å resolution, by 
omitting the preQ1 molecule and a spherical cushion of 2 Å radius around it prior to simulated 
annealing, contoured at 1.0 σ. 
 
  
 
Supplementary Figure 2.  Evidence for correct sequence register of the crystallographic model.  
Portion of the anomalous difference Fourier synthesis calculated with amplitudes from Crystal 
III, and phases from the molecular replacement solution using the refined structure from Crystal 
I as the search model (see Supplementary Methods, online), contoured at 7 σ (blue mesh).  The 
10.5 σ peak is consistent with the presence of a 5-iodouracil at this position of the RNA, 
confirming the sequence register of the crystallographic model. 
  
 
Supplementary Figure 3.  Comparison of the structures of three independently evolved small 
molecule binding H-type (or ABAB) pseudoknots.  (a) Schematic depiction of the structural 
elements of an H-type pseudoknot (after Supplementary ref. 1)  (b) Cartoon representation of the 
structure of the wild-type B. subtilis preQ1 riboswitch.  The RNA is colored as in (a); the bound 
ligand is in green.  Uniquely among the three RNA structures in this figure, this riboswitch RNA 
has an L2 loop (yellow) of non-zero length.  (c) Cartoon representation of the structure of the 
biotin aptamer2 (PDB code 1F27).  The bound biotin is colored green.  In this crystal structure, 
there is a covalent break in the RNA backbone (gray spheres).  Note binding of biotin between 
helices S1 and S2, despite the RNA having an L2 of zero length.  (d) Cartoon representation of 
the structure of the class II S-adenosylmethionine (SAM-II) riboswitch3 (PDB code 2QWY), 
colored as in the preceding panels.  This pseudoknotted RNA also has L2 of length zero.  The 
adenine moiety of S-adenosylmethionine binds into a pocket formed by a gap in the sequence of 
helix S2. 
  
 
Supplementary Figure 4.  Discrimination between G, preQ1 and preQ0 by the B. subtilis class-I 
riboswitch. (a) Chemical structure of G.  The nitrogen at position 7, a potential hydrogen bond 
acceptor, is indicated.  (b) Structure of preQ1.  Note the aminomethyl group that is attached to a 
carbon at position 7.  The preQ1 riboswitch needs to discriminate against guanine, and does so 
employing the full hydrogen bonding potential of the amine of the aminomethyl group.  Thick 
arrows denote hydrogen bonds made by the preQ1 riboswitch to preQ1.  Except for one lone pair 
of the carbonyl oxygen at position 6, every possible hydrogen bond donor and acceptor of the 
small molecule is recognized by the riboswitch.  (c) Structure of preQ0, the immediate 
biosynthetic precursor to preQ1.  This compound has a nitrile at position 7.  Presumably, the 
riboswitch discriminates against preQ0 because the nitrile group cannot donate hydrogen bonds, 
and because its linear structure clashes against the binding pocket of the riboswitch which is 
shape-complementary to the bent (due to the tetrahedral methylene group) structure of the 
aminomethyl group. 
  Start Codon PreQ1 switch  Possible antiterminator pairs Terminator 
>Lysinibacillus sphaericus C3-41 (NC_010382.1) 
Residues shown: 3036970…3037103 
Downstream gene: NADPH-dependent 7-cyano-7-deazaguanine reductase 
ON: 
agaggttcat agctgatacc ctctataaaa aactatggaa acatgacaat ttgccatgtc 
catatcggac gtggcttttt tatgtttaga cgtatgtttt aatagatgaa ttggtaaagc 
ctctcttgaa agtg  
OFF: 
agaggttcat agctgatacc ctctataaaa aactatggaa acatgacaat ttgccatgtc 
catatcggac gtggcttttt tatgtttaga cgtatgtttt aatagatgaa ttggtaaagc 
ctctcttgaa agtg 
 
>Staphylococcus saprophyticus subsp. Saprophyticus ATCC 15305 (NC_007350.1)  
Residues shown: 2076129…2076272 
Downstream gene: Hypothetical protein YP_302098.1 
ON: 
agaggttcct agctgatacc ctctataaaa aactagacac atgtacaacg tctgtctttt 
ttatagagat aggcgttttt ttatgcgctt atctaaaccc tgtaccagtt agttcgacta 
tttttaagga gtgcaagaca aatg 
OFF: 
agaggttcct agctgatacc ctctataaaa aactagacac atgtacaacg tctgtctttt 
ttatagagat aggcgttttt ttatgcgctt atctaaaccc tgtaccagtt agttcgacta 
tttttaagga gtgcaagaca aatg 
 
>Oceanobacillus iheyensis HTE831 (NC_004193.1)  
Residues show: 2245681…2245793 
Downstream gene: 7-cyano-7deazaguanine reductase 
ON: 
agaggttctt agcttcaacc ctctataaaa aactaaggac aaacaatgat ttattcaagt 
catgttcctt aggggacatg acttttttta tggaaaagga ggtaataagt atg 
OFF: 
agaggttctt agcttcaacc ctctataaaa aactaaggac aaacaatgat ttattcaagt 
catgttcctt aggggacatg acttttttta tggaaaagga ggtaataagt atg 
 
 
>Geobacillus thermodenitrificans NG80-2 (NC_009328.1)  
Residues shown: 940287…940404 
Downstream gene: aluminum resistance protein 
ON: 
     agagg tttctagcaa aaccctctat aaaaaactag ggacggctgt atcctagggg 
tatggccttt tttgttttgg aaacctcttc ttctgtcgat tcagaaggag gttagtcaag 
atg 
OFF: 
     agagg tttctagcaa aaccctctat aaaaaactag ggacggctgt atcctagggg 
tatggccttt tttgttttgg aaacctcttc ttctgtcgat tcagaaggag gttagtcaag 
atg 
 >Bacillus pumilus SAFR-032 (NC_009848.1)  
Residues shown: 1324519…1324720 
Downstream gene: transcriptional regulator 
ON 
     agagg ttctagcaaa accctctata aaaaactaag gacttgccgt atccttggat 
gtggcatttt ttatttttta tggctgggac acctcataca catgtaaagg tgtcttttct 
tttgagaaaa ataggggttt tcatgagcct ttcagatgca gctttgtacg atggtataga 
tctgcaaaag gaggagaaca gaagatg 
OFF 
     agagg ttctagcaaa accctctata aaaaactaag gacttgccgt atccttggat 
gtggcatttt ttatttttta tggctgggac acctcataca catgtaaagg tgtcttttct 
tttgagaaaa ataggggttt tcatgagcct ttcagatgca gctttgtacg atggtataga 
tctgcaaaag gaggagaaca gaagatg 
 
 
>Bacillus subtilis subsp. subtilis str. 168 (NC_000964.2) 
Residues shown: 1438587…1438758 
Downstream gene: ykvJ 
ON: 
     agagg ttctagctac accctctata aaaaactaag gacgagctgt atccttggat 
acggcctttt ttatgttttt ctagagcacc ttccgaaaaa aggtgttttt ttgcgtgaat 
tagctgtagc gatgtctctc gccggcgttt ttattgcgga gaaggagagg aatcatg 
OFF: 
     agagg ttctagctac accctctata aaaaactaag gacgagctgt atccttggat 
acggcctttt ttatgttttt ctagagcacc ttccgaaaaa aggtgttttt ttgcgtgaat 
tagctgtagc gatgtctctc gccggcgttt ttattgcgga gaaggagagg aatcatg 
 
Supplementary Figure 5.  Sequence analysis of selected 5'-UTRs that contain class I, sub-type 
II preQ1 riboswitches.  Each of these UTRs appear to control gene expression by transcriptional 
attenuation in a preQ1-dependent manner.  Highlighted residues in each sequence include the 
preQ1 binding domain (yellow), anti-terminator helix (red), terminator helix (cyan) and start 
codon (green).   
 
Although this figure is limited to class-I preQ1 riboswitches, the sequestration of a 3' single-
stranded extension into the riboswitch as a function of metabolite binding could be a strategy 
more widely employed by other riboswitches.  Indeed class-II preQ1 riboswitches are thought to 
fold into H-type pseudoknots 4.   
 
At present there is no evidence whether the two putative secondary structures shown in Fig. 1c 
interconvert, or whether formation of either (in the absence or presence of sufficient 
concentration of preQ1, respectively) is under kinetic control, as in the case of the FMN 
riboswitch studied by Wickiser et al. 5.  Therefore, the secondary structures of the UTR shown in 
that figure remain purely hypothetical.   
 
 
 Supplementary Table 1.  Data collection and refinement statistics.  
 
 Crystal I Crystal II Crystal III 
Data collection    
Space group R32 P3221 R32 
Cell dimensions      
    a, b, c (Å) 76.81, 76.81, 85.90  78.21, 78.21, 85.22  78.40, 78.40, 459.94 
    α, β, γ  (°)  90, 90, 120 90, 90, 120 90, 90, 120 
Resolution (Å) 30.0-2.2 (2.3-2.2)* 30-2.85 (2.95-2.85) 30-3.0 (3.1-3.0) 
Rmerge 8.5 (41.4) 12.6 (46.0) 12.5 (34.8) 
<I> / <σ(I)> 23.1 (2.2) 23.7 (3.4) 28.1 (8.1) 
Completeness (%) 95.0 (69.1) 96.8 (68.3) 97.5 (86.3) 
Redundancy 8.8 (2.6) 11.3 (9.2) 12.3 (9.6) 
    
Refinement    
Resolution (Å) 30.0-2.2 30-2.85  
No. reflections 4592 (483)† 7122 (390)†  
Rwork / Rfree (%) 23.0/26.8 21.4/26.7  
No. atoms    
    RNA 614 1991  
    PreQ1 13 39  
    Ion 4 9  
    Water 62 21  
B-factors    
    RNA 34.2 52.5  
    PreQ1 22.7 43.2  
    Ion 25.7 60.2  
    Water 34.8 30.7  
R.m.s. deviations    
    Bond lengths (Å) 0.00363 0.00527  
    Bond angles (°) 1.3252 1.3270  
*A single crystal was used for each dataset. *Values in parentheses are for highest-resolution shell. 
†Values in parentheses are for the cross-validation set. 
 
  
 Supplementary Table 2.  Tertiary interactions formed by L1, L2, and L3 residues of the preQ1 
riboswitch (nucleotides from other segments of the RNA identified in black).  
 
Pair partners Distance (Å) Type of interaction 
   
U6 N3 – A29 N7 2.7 Cis Watson-Crick • Hoogsteen pair 
U6 O4 – A29 N6 2.8  
   
U7 N3 – A30 N7 3.1 Cis Watson-Crick • Hoogsteen pair 
U7 O4 – A30 N6 3.1  
   
G11 N2 – A16 N1 3.1 a Trans sugar edge • Watson-Crick pair 
G11 N3 – A16 N6 3.0 a  
   
A14 N1 – U32 O2' 2.8 a "Reverse Type II" A-minor motif 
A14 N6 – U32 O2 3.3 a  
   
A23 N1 – G2 O2' 2.9 "Reverse Type II" A-minor motif 
A23 N6 – G2 N3 3.1  
   
U24 O4 – G2 N2 3.0 Single H-bond 
   
A25 N1 – C21 O2' 2.6 Single H-bond; part of triple with below. 
   
A25 N6 – A3 N3 2.9 Cis Hoogsteen•sugar edge; with preceding, 
A25 N7 – A3 O2' 3.2 part of inclined Hoogsteen • minor groove 
   
A26 N1 – U20 O2' 3.1 Cis Watson-Crick•sugar edge; with next, 
A26 N6 – U20 O2 2.7 part of inclined Hoogsteen • minor groove 
   
A26 N6 – G4 N3 2.9 Cis Hoogsteen•sugar edge; with preceding, 
A26 N7 – G4 O2' 2.6 part of inclined Hoogsteen • minor groove 
   
A27 N1 – C19 O2' 2.7 Cis Hoogsteen•sugar edge; together with below, 
A27 N6 – C19 O2 2.9 part of a triple. 
   
A27 N6 – G4 N2 3.2 Single H-bond; part of a triple with above 
   
A28 N1 – G5 N2 3.0 Trans Watson-Crick • sugar edge 
A28 N6 – G5 N3 3.1  
A28 N6 – G5 O2' 2.9  
aThese distances are from the Crystal II structure (chain B).  All others are from the Crystal I 
structure. 
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Crystallization and data collection 
Three 34-nt oligonucleotides of sequence 5'-AGA GGU UCU AGC UAC ACC CUC UAU AAA 
AAA CUA A-3' (Crystal I), 5'-AGA GGU UCU AGC ACA UCC CUC UAU AAA AAA CUA 
A-3´ (Crystal II), and 5'-AGA GGU UCU AGC ACA UCC CXC UAU AAA AAA CUA A-3'  
(where X denotes 5-iodouridine, Crystal III) were purchased from Dharmacon, Inc., deprotected 
following manufacturer's instructions, and used without further purification.  The underlined 4-nt 
segment differs between the RNA that yielded Crystal I and the two other RNAs.  The RNAs 
used for Crystal II and Crystal III correspond to the wild-type B. subtilis queC 5'-UTR sequence6 
(excepting the 5-iodouridine in the Crystal III RNA).  The sequence of the RNA used for Crystal 
I is a B. subtilis queC 5'-UTR sequence variant reported by 7.  Although the underlined 
nucleotides are disordered in our Crystal I structure (see below), this sequence variant produced 
better diffracting crystals with a smaller unit cell than the wild-type sequence (Supplementary 
Table 1, online).  Purified preQ1 was a gift from Professor Raven Huang (University of Illinois 
at Urbana-Champaign).   
 
All crystals were grown by vapor diffusion at 296 K.  For Crystal I, an RNA solution containing 
0.37 mM RNA, 0.5 mM preQ1, 10 mM MgCl2, 10 mM Hepes-KOH pH 7.5, and 1 mM spermine 
was incubated for 15 minutes at 315 K prior to mixing with an equal volume of reservoir 
solution comprised of 30% (v/v) polyethylene glycol (PEG) 200, 50 mM CaCl2, 100 mM Hepes-
KOH pH 7.0.   For crystal II, an RNA solution containing 0.37 mM RNA, 0.5 mM preQ1, 10 
mM MgCl2, 10 mM Hepes-KOH, pH 7.5, and 1 mM spermine was incubated for 15 minutes at 
315 K prior to mixing with an equal volume of reservoir solution comprised of 25% (v/v) PEG 
monomethyl ether (MME) 550, 50 mM CaCl2, 100 mM Hepes-KOH pH 7.0.  For crystal III, an 
RNA solution containing 0.37 mM RNA, 0.5 mM preQ1, 10 mM MgCl2, 10 mM Hepes-KOH pH 
7.5, 50 mM CaCl2 was incubated for 15 minutes at 315 K, and briefly centrifuged to remove 
precipitated RNA prior to mixing with an equal volume of reservoir solution comprised of 35% 
(v/v) pentaerythritol propoxylate (17/8 PO/OH) (Hampton Research) and 0.2 M KCl.  Crystals 
(unit cell parameters in Supplementary Table 1, online) appeared within one week and grew to 
maximum dimensions of 150x150x30 µm3.   
 
Crystal I was transferred to 50% (v/v) PEG 200, 50 mM CaCl2, 100 mM Hepes-KOH pH 7.0 
prior to flash-freezing by plunging into liquid nitrogen while supported in a nylon loop.  Crystal 
II was transferred to 45% (v/v) PEG 550 MME, 50 mM CaCl2, 100 mM Hepes-KOH pH 7.0 
prior to flash-freezing.  Crystal III flash frozen directly from mother liquor by plunging into 
liquid nitrogen while supported in a nylon loop.  Diffraction data were collected in oscillation 
mode at 100 K at beamline 5.0.1 of the Advanced Light Source using 1.0 Å X-radiation, 
Lawrence Berkeley National Laboratory for Crystal I, and with a copper rotating anode source 
(1.5418 Å X-radiation) for Crystals II and III, and reduced with the HKL package8. 
 
Structure determination and refinement 
The riboswitch structure in Crystal I was determined by molecular replacement with PHASER9,10 
using two A-form RNA duplexes of sequence 5'-GAGGG-3' and 5'-UAG-3' (and their 
complements) as independent starting search models.  Simulated annealing, energy 
minimization, and individual isotropic B-factor refinement11 against all data (with a random 10% 
 excluded for cross-validation) to 2.2 Å of the top solution (Z-scores for rotation and translation 
searches of 3.2 and 4.9, respectively; overall log-likelihood gain of 140) resulted in a model with 
free-R factor of 50.1%, and an electron density map with additional interpretable features.  
Eighteen iterative rounds of manual model building12, simulated annealing, energy minimization, 
and individual isotropic B-factor refinement11 produced the current model of the single 
riboswitch RNA in the asymmetric unit of this crystal form (statistics in Supplementary Table 1 
online).  A composite simulated annealing omit 2|Fo|-|Fc| map (ref 11) calculated with the final 
model shows clear electron density for all the RNA, except residues 12-16, inclusive 
(Supplementary Fig. 1a online).  The bound preQ1 molecule has electron density that clearly 
indicates the conformation of its aminomethyl group in an anneal-omit 2|Fo|-|Fc| map 
(Supplementary Fig. 1b online).  Analysis of dissolved crystals on 8M Urea-PAGE 
demonstrated that the RNA in the crystalline state is intact (not shown).  Therefore, the lack of 
electron density for residues 12-16 indicates crystallographic disorder, not RNA scission.  The 
σA coordinate error for this structure is 0.32 Å (0.38 Å for the cross-validation set). 
 
The riboswitch structure in Crystal II was solved by molecular replacement with PHASER9 
using the refined Crystal I model to search for the three crystallographically independent 
riboswitch RNAs in the asymmetric unit of Crystal II.  The initial solution had Z-scores for 
rotation and translation searches of 4.6 and 31.4, respectively, and an overall log-likelihood gain 
of 1428.  Iterative rounds of manual model building12, simulated annealing, energy minimization, 
and individual isotropic B-factor refinement11 produced the current model, which comprises the 
complete RNA chain, except residues 12 and 13 and the nucleobase of residue 15, which are 
presumed disordered (statistics in Supplementary Table 1 online). The σA coordinate error for 
this structure is 0.65 Å (0.76 Å for the cross-validation set). 
 
The sequence register of the crystallographic model was confirmed by carrying out molecular 
replacement against the Crystal III dataset with the refined model from Crystal I as the search 
model.  Anomalous difference Fourier syntheses with the model phases from the top PHASER 
solution (Z-scores for rotation and translation searches of 4.6 and 18.6, respectively, and an 
overall log-likelihood gain of 288) show an electron density feature with a peak height of 10.5 
standard deviations above mean peak height (σ) adjacent to the 5 position of residue U20 
(Supplementary Fig. 2 online).  
 
Figures 1a, 1b, and 2b depict chain B from the Crystal II structure of the wild-type B. subtilis 
queC 5'-UTR sequence RNA6.  Figures 1c, 1d, and 2a depict the model from the Crystal I 
structure of the B. subtilis queC 5'-UTR sequence variant reported by Barrick et al.7  Figures 
were prepared with RIBBONS13 and PyMOL14.  Solvent accessible surface areas of preQ1 were 
calculated using CNS11 with a probe radius of 1.4 Å (and the Crystal I structure, for the bound 
state).   
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